Analysts’ Recent Ratings Updates for 22nd Century Group (XXII)

A number of research firms have changed their ratings and price targets for 22nd Century Group (NASDAQ: XXII):

• 12/13/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 12/7/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 12/1/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/25/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/19/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/13/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/7/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/1/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 10/26/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 10/20/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 10/14/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.

22nd Century Group Trading Down 33.2 %

Shares of XXII traded down $0.02 during mid-day trading on Friday, hitting $0.05. The company had a trading volume of 41,891,944 shares, compared to its average volume of 3,301,603. 22nd Century Group, Inc. has a 1-year low of $0.04 and a 1-year high of $4.31. The company has a quick ratio of 0.93, a current ratio of 1.09 and a debt-to-equity ratio of 1.59. The business’s 50-day simple moving average is $0.11 and its 200-day simple moving average is $0.43. The stock has a market cap of $2.28 million, a PE ratio of 0.00 and a beta of 1.50.

22nd Century Group (NASDAQ:XXII) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The firm had revenue of $5.95 million during the quarter.

Institutional Investors Weigh In On 22nd Century Group

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP bought a new stake in 22nd Century Group, Inc. (NASDAQ:XXII) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group as of its most recent SEC filing. Institutional investors and hedge funds own 18.06% of the company’s stock.

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.